WO2007117289A3 - Methods for treating or preventing erectile dysfunction or urinary incontinence - Google Patents

Methods for treating or preventing erectile dysfunction or urinary incontinence Download PDF

Info

Publication number
WO2007117289A3
WO2007117289A3 PCT/US2006/047199 US2006047199W WO2007117289A3 WO 2007117289 A3 WO2007117289 A3 WO 2007117289A3 US 2006047199 W US2006047199 W US 2006047199W WO 2007117289 A3 WO2007117289 A3 WO 2007117289A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
methods
urinary incontinence
erectile dysfunction
preventing erectile
Prior art date
Application number
PCT/US2006/047199
Other languages
French (fr)
Other versions
WO2007117289A2 (en
Inventor
Andrew L Salzman
Original Assignee
Inotek Pharmaceuticals Corp
Andrew L Salzman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inotek Pharmaceuticals Corp, Andrew L Salzman filed Critical Inotek Pharmaceuticals Corp
Publication of WO2007117289A2 publication Critical patent/WO2007117289A2/en
Publication of WO2007117289A3 publication Critical patent/WO2007117289A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to methods for treating or preventing erectile dysfunction or urinary incontinence, comprising administering to a subject in need thereof an effective amount of a compound of the invention.
PCT/US2006/047199 2005-12-14 2006-12-11 Methods for treating or preventing erectile dysfunction or urinary incontinence WO2007117289A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75085405P 2005-12-14 2005-12-14
US60/750,854 2005-12-14

Publications (2)

Publication Number Publication Date
WO2007117289A2 WO2007117289A2 (en) 2007-10-18
WO2007117289A3 true WO2007117289A3 (en) 2008-01-03

Family

ID=38581516

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047199 WO2007117289A2 (en) 2005-12-14 2006-12-11 Methods for treating or preventing erectile dysfunction or urinary incontinence

Country Status (1)

Country Link
WO (1) WO2007117289A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101763222B1 (en) 2014-06-27 2017-07-31 희성소재 (주) Hetero-cyclic compound and organic light emitting device using the same
US11127905B2 (en) * 2015-07-29 2021-09-21 Universal Display Corporation Organic electroluminescent materials and devices
US11476425B2 (en) 2018-09-28 2022-10-18 Lt Materials Co., Ltd. Heterocyclic compound and organic light emitting element comprising same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608082B1 (en) * 1998-04-28 2003-08-19 Lion Bioscience Ag Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands
US20040229895A1 (en) * 2003-02-28 2004-11-18 Inotek Pharmaceuticals Corporation Tetracyclic benzamide derivatives and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608082B1 (en) * 1998-04-28 2003-08-19 Lion Bioscience Ag Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands
US20040229895A1 (en) * 2003-02-28 2004-11-18 Inotek Pharmaceuticals Corporation Tetracyclic benzamide derivatives and methods of use thereof

Also Published As

Publication number Publication date
WO2007117289A2 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
WO2006009718A3 (en) Methods for treating or preventing erectile dysfunction or urinary incontinence
WO2007073505A3 (en) Trpa1 inhibitors for treating pain
WO2009052431A3 (en) Cd19 binding agents and uses thereof
TW200714283A (en) Method and composition for treating peripheral vascular diseases
AU2006279280A8 (en) Methods and compositions for treating neurological disease
WO2006122156A3 (en) Compounds for modulating trpv3 function
WO2007056124A3 (en) Compounds for modulating trpv3 function
WO2006096490A3 (en) ANTI-MAdCAM ANTIBODY COMPOSITIONS
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2007112073A3 (en) Methods for modulating bladder function
WO2006073457A8 (en) Bioactive compounds and methods of uses thereof
WO2008060374A3 (en) Methods and compositions useful for diabetic wound healing
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2006091459A3 (en) Compositions and methods for treating vascular permeability
WO2007011760A3 (en) Inhibitors of mitotic kinesin
WO2007011962A3 (en) Treatment of cancer
WO2006127900A3 (en) Tl1a in the treatment of disease
WO2007011759A3 (en) Inhibitors of mitotic kinesin
WO2007109105A3 (en) Flavivirus inhibition by sultams and related compounds
WO2007084857A3 (en) Methods and compositions for treating cell proliferative disorders
WO2008112659A3 (en) Regulation of osteopontin
WO2007144057A3 (en) Antimicrobial carbon
WO2006034035A3 (en) Treatment of ischemia
WO2007146335A3 (en) Compounds and compositions for treatment of cancer
WO2007106915A3 (en) Antibodies to egfl7 and methods for their use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06850576

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06850576

Country of ref document: EP

Kind code of ref document: A2